FDA authorizes Johnson & Johnson's one-dose COVID vaccine, doses expected to start rolling next week

USA Today

Karen Weintraub and Jordan Culver USA TODAY
Picture Courtesy: USA Today
Picture Courtesy: USA Today

The U.S. Food and Drug Administration has authorized a third COVID-19 vaccine for public use.

As expected on Saturday, acting Commissioner Dr. Janet Woodcock granted an emergency use authorization for a vaccine developed by Janssen Pharmaceuticals, a Johnson & Johnson company. 

About 4 million doses of the new vaccine should be made available next week, 20 million total during March, and another 80 million by the end of June. Because the vaccine requires only one dose, it will help protect 100 million people and take effect more rapidly than the two-dose vaccines.

The J&J vaccine joins two others, one from Pfizer-BioNTech and the other from Moderna, which have been given to nearly 50 million Americans since they were authorized in December.

Publish : 2021-02-28 12:14:00

Give Your Comments